Alkylamido compounds and uses thereof
Abstract
Claim 1: A compound of formula (1) wherein X is C1-3 alkylene, optionally substituted with one, two or three substituents selected from halogen or hydroxyl; R1 is selected from the group consisting of C1-6 alkyl, C3-5 cycloalkyl, C3-6 alkenyl, and C2-6 alkynyl; R2 is selected from the group consisting of hydrogen and C1-6 alkyl; R3 is independently selected, for each occurrence of the group consisting of hydrogen, C1-6 alkoxy, C1-6 alkyl, cyano, C3-6 cycloalkyl, halogen, hydroxyl, and nitro; R4 is selected from the group consisting of hydrogen and C1-6 alkyl; R5 is hydrogen, C1-6 alkyl; or its pharmaceutically acceptable salts or N-oxides. Claim 11: A pharmaceutical composition comprising a compound, or a pharmaceutically acceptable salt or N-oxide thereof, according to any one of claims 1-10 and a pharmaceutically acceptable carrier.
Term
No projected expiry on record.
- Priority
- Filed
- Granted
- Today
94 members in 25 offices
Priority claims3
| Document | Office | Kind | Date |
|---|---|---|---|
| 09425056 | European Patent Office (EPO) | A | |
| 17906209 | United States of America | P | |
| 28746109 | United States of America | P |
Members94
| Document | Office | Kind | |
|---|---|---|---|
| CA2752623A1 | Canada | A1 | |
| CA2752626A1 | Canada | A1 | |
| WO2010091892A2 | World Intellectual Property Organization (WIPO) | A2 | |
| WO2010091894A2 | World Intellectual Property Organization (WIPO) | A2 | |
| WO2010091892A3 | World Intellectual Property Organization (WIPO) | A3 | |
| WO2010091894A3 | World Intellectual Property Organization (WIPO) | A3 | |
| AU2010213093A1 | Australia | A1 | |
| AU2010213095A1 | Australia | A1 | |
| MX2011008601A | Mexico | A | |
| MX2011008602A | Mexico | A | |
| IL214664D0 | Israel | D0 | |
| IL214665D0 | Israel | D0 | |
| KR20110120945A | Republic of Korea | A | |
| KR20110120946A | Republic of Korea | A | |
| EP2396081A2 | European Patent Office (EPO) | A2 | |
| EP2396082A2 | European Patent Office (EPO) | A2 | |
| CN102316931A | China | A | |
| CN102316932A | China | A | |
| EA201171062A1 | Eurasian Patent Organization (EAPO) | A1 | |
| EA201171063A1 | Eurasian Patent Organization (EAPO) | A1 | |
| US2012053244A1 | United States of America | A1 | |
| US2012053245A1 | United States of America | A1 | |
| AR080596A1This record | Argentina | A1 | |
| ZA201106256B | South Africa | B | |
| JP2012517968A | Japan | A | |
| JP2012517969A | Japan | A | |
| EP2396082B1 | European Patent Office (EPO) | B1 | |
| NZ595076A | New Zealand | A | |
| NZ595080A | New Zealand | A | |
| PT2396082E | Portugal | E | |
| ES2429143T3 | Spain | T3 | |
| UA105037C2 | Ukraine | C2 | |
| US8754127B2 | United States of America | B2 | |
| CN102316932B | China | B | |
| US8796334B2 | United States of America | B2 | |
| EA020198B1 | Eurasian Patent Organization (EAPO) | B1 | |
| CN102316931B | China | B | |
| EP2805746A1 | European Patent Office (EPO) | A1 | |
| JP2014237692A | Japan | A | |
| JP5645851B2 | Japan | B2 | |
| US2015051285A1 | United States of America | A1 | |
| EA020856B1 | Eurasian Patent Organization (EAPO) | B1 | |
| JP5715070B2 | Japan | B2 | |
| US2015148418A1 | United States of America | A1 | |
| CN104666288A | China | A | |
| JP2015155427A | Japan | A | |
| UA109525C2 | Ukraine | C2 | |
| AU2010213095B2 | Australia | B2 | |
| IL214664A | Israel | A | |
| JP5820030B2 | Japan | B2 | |
| AU2010213093B2 | Australia | B2 | |
| BRPI1008752A2 | Brazil | A2 | |
| BRPI1011226A2 | Brazil | A2 | |
| US2016338927A1 | United States of America | A1 | |
| US9511041B2 | United States of America | B2 | |
| IL214665A | Israel | A | |
| EP2396081B1 | European Patent Office (EPO) | B1 | |
| US2017172956A1 | United States of America | A1 | |
| CA2752623C | Canada | C | |
| DK2396081T3 | Denmark | T3 | |
| PT2396081T | Portugal | T | |
| CN104666288B | China | B | |
| ES2630044T3 | Spain | T3 | |
| KR101776337B1 | Republic of Korea | B1 | |
| LT2396081T | Lithuania | T | |
| HRP20170936T1 | Croatia | T1 | |
| SI2396081T1 | Slovenia | T1 | |
| PL2396081T3 | Poland | T3 | |
| KR101800901B1 | Republic of Korea | B1 | |
| HUE032999T2 | Hungary | T2 | |
| CY1119225T1 | Cyprus | T1 | |
| US9901557B2 | United States of America | B2 | |
| CA2752626C | Canada | C | |
| US10137101B2 | United States of America | B2 | |
| US2018369178A1 | United States of America | A1 | |
| US10398667B2 | United States of America | B2 | |
| US2019269637A1 | United States of America | A1 | |
| BRPI1011226B1 | Brazil | B1 | |
| BRPI1008752B1 | Brazil | B1 | |
| EP2805746B1 | European Patent Office (EPO) | B1 | |
| US2020188340A1 | United States of America | A1 | |
| DK2805746T3 | Denmark | T3 | |
| PT2805746T | Portugal | T | |
| LT2805746T | Lithuania | T | |
| SI2805746T1 | Slovenia | T1 | |
| HUE050267T2 | Hungary | T2 | |
| EP3744398A1 | European Patent Office (EPO) | A1 | |
| US2020383942A1 | United States of America | A1 | |
| HRP20201184T1 | Croatia | T1 | |
| ES2806691T3 | Spain | T3 | |
| US10959970B2 | United States of America | B2 | |
| CY1123213T1 | Cyprus | T1 | |
| US2022354809A1 | United States of America | A1 | |
| MX381002B | Mexico | B |
1 legal event, as the office reported them to INPADOC
Events
| Event | Code | |
|---|---|---|
| Grant, registrationFG | FG |
Numbers
- Application
- 100100447
Titles2
- English
- RENTAL COMPOUNDS AND PHARMACEUTICAL COMPOSITIONS
- Spanish
- COMPUESTOS ALQUILAMIDO Y COMPOSICIONES FARMACEUTICAS
Classification
- CPC, 17
- A61K31/196
- A61K2800/78
- A61Q19/02
- A61Q19/06
- A61Q19/08
- C07D307/79
- C07D319/08
- C07C233/54
- A61K8/42
- A61K8/44
- A61P17/10
- A61Q7/00
- A61Q19/008
- A61Q7/02
- C07C235/38
- A61K2121/00
- A61Q5/00